Medico Remedies Limited (NSE:MEDICO)
37.81
-0.51 (-1.33%)
Apr 2, 2026, 3:29 PM IST
Medico Remedies Revenue
Medico Remedies had revenue of 586.83M INR in the quarter ending December 31, 2025, with 48.60% growth. This brings the company's revenue in the last twelve months to 1.91B, up 26.44% year-over-year. In the fiscal year ending March 31, 2025, Medico Remedies had annual revenue of 1.51B with 4.15% growth.
Revenue (ttm)
1.91B
Revenue Growth
+26.44%
P/S Ratio
1.64
Revenue / Employee
8.96M
Employees
213
Market Cap
3.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.51B | 60.20M | 4.15% |
| Mar 31, 2024 | 1.45B | 44.83M | 3.19% |
| Mar 31, 2023 | 1.40B | 194.16M | 16.04% |
| Mar 31, 2022 | 1.21B | -13.69M | -1.12% |
| Mar 31, 2021 | 1.22B | 337.54M | 38.08% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nectar Lifesciences | 16.70B |
| Ind-Swift Laboratories | 5.94B |
| Sigachi Industries | 4.85B |
| Beta Drugs | 3.85B |
| Jagsonpal Pharmaceuticals | 2.82B |
| Sakar Healthcare | 2.31B |
| Valiant Laboratories | 2.03B |
| Bafna Pharmaceuticals | 1.47B |
Medico Remedies News
- 6 months ago - Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government - Business Upturn